Literature DB >> 8563048

Histological responses to Helicobacter pylori infection: gastritis, atrophy and preneoplasia.

M F Dixon1.   

Abstract

It is interesting that the principal histological features of acute H. pylori gastritis, surface epithelial degeneration and neutrophil polymorph infiltration, remain as the most sensitive indicators of the 'activity' of infection in the chronic phase. It is not surprising therefore that these are the first features to resolve after successful H. pylori eradication therapy. In one of the earliest studies of histological response to eradication, McNulty et al (1986) endoscoped patients immediately after a three-week treatment regime and found a highly significant decline in polymorph scores. The response was even more striking four weeks after the end of treatment, as at that time biopsies from responders were virtually devoid of polymorphs (Valle et al, 1991). Indeed the disappearance of polymorphs from a post-treatment biopsy is a useful indicator of successful eradication. Less attention has been paid to the recovery of the surface epithelium yet this is an impressive feature when comparing pre- and post-treatment biopsies. Using subjective grading of surface epithelial lesions, Solcia et al (1994) found a dramatic and highly significant improvement in mean grade immediately after anti-H. pylori treatment. Recently a morphometric approach was used to demonstrate a significant increase in surface epithelial cell height corresponding to the recovery that accompanies successful H. pylori eradication (Hassan et al, 1993). Chronic inflammatory cell infiltrate resolution is much slower. There is only a gradual reduction in cell density so that even 6 months after eradication treatment the mean score had only fallen by 50% of pre-treatment values (Solcia et al, 1994). In the author's experience, a minor increase in such cells persists for many months and may never completely resolve, in that more lymphocytes and plasma cells are seen than in a truly normal (pre-infection) stomach. Valle et al (1991) found resolution of chronic inflammation in only 15% of subjects at 6 months and in 51% at one year after eradication. The long delay in disappearance of lymphocytes and plasma cells poses a question over continuing antigenic stimulation in the absence of infection. Possible answers could involve persistence of antigenic moieties in dendritic cells of the lamina propria, or sensitization to host antigens brought about by infection so that an element of autoimmunity persists after eradication. Unravelling these mechanisms will add important new elements to our understanding of the long-term consequences of this fascinating infection.

Entities:  

Mesh:

Year:  1995        PMID: 8563048     DOI: 10.1016/0950-3528(95)90043-8

Source DB:  PubMed          Journal:  Baillieres Clin Gastroenterol        ISSN: 0950-3528


  15 in total

Review 1.  The interplay between Helicobacter pylori, gastro-oesophageal reflux disease, and intestinal metaplasia.

Authors:  P Malfertheiner; U Peitz
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

2.  Treatment of Helicobacter pylori in functional dyspepsia resistant to conventional management: a double blind randomised trial with a six month follow up.

Authors:  H R Koelz; R Arnold; M Stolte; M Fischer; A L Blum
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

3.  Increased expression of cyclooxygenase-2 in first-degree relatives of gastric cancer patients.

Authors:  Jin-Ting Zhang; Ming-Wei Wang; Zhen-Long Zhu; Xiao-Hui Huo; Jian-Kun Chu; Dong-Sheng Cui; Liang Qiao; Jun Yu
Journal:  World J Gastroenterol       Date:  2005-08-21       Impact factor: 5.742

4.  A genetic basis for atrophy: dominant non-responsiveness and helicobacter induced gastritis in F(1) hybrid mice.

Authors:  P Sutton; J Wilson; R Genta; D Torrey; A Savinainen; J Pappo; A Lee
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

5.  The endotoxin of Helicobacter pylori is a modulator of host-dependent gastritis.

Authors:  T Sakagami; J Vella; M F Dixon; J O'Rourke; F Radcliff; P Sutton; T Shimoyama; K Beagley; A Lee
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

6.  Analysis of cell damage and proliferation in Helicobacter pylori-infected human gastric mucosa from patients with gastric adenocarcinoma.

Authors:  N Yabuki; H Sasano; M Tobita; A Imatani; T Hoshi; K Kato; S Ohara; S Asaki; T Toyota; H Nagura
Journal:  Am J Pathol       Date:  1997-09       Impact factor: 4.307

7.  Helicobacter pylori directs tolerogenic programming of dendritic cells.

Authors:  Min Zhang; Maochang Liu; Jay Luther; John Y Kao
Journal:  Gut Microbes       Date:  2010-07-16

8.  Helicobacter pylori immune escape is mediated by dendritic cell-induced Treg skewing and Th17 suppression in mice.

Authors:  John Y Kao; Min Zhang; Mark J Miller; Jason C Mills; Baomei Wang; Maochang Liu; Kathyn A Eaton; Weiping Zou; Bradford E Berndt; Tyler S Cole; Tomomi Takeuchi; Stephanie Y Owyang; Jay Luther
Journal:  Gastroenterology       Date:  2009-11-18       Impact factor: 22.682

9.  Critical role of Helicobacter pylori in the pattern of gastritis and carditis in residents of an area with high prevalence of gastric cardia cancer.

Authors:  Masoud Sotoudeh; Mohammad H Derakhshan; Behnoosh Abedi-Ardakani; Mehdi Nouraie; Abass Yazdanbod; Seyyed Mohammad Tavangar; Javad Mikaeli; Shahin Merat; Reza Malekzadeh
Journal:  Dig Dis Sci       Date:  2007-05-10       Impact factor: 3.199

10.  Helicobacter pylori induces RANTES through activation of NF-kappa B.

Authors:  Naoki Mori; Alan M Krensky; Romas Geleziunas; Akihiro Wada; Toshiya Hirayama; Chihiro Sasakawa; Naoki Yamamoto
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.